By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed
Advertisement
Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed
Advertisement
Latest Updated Articles
Back to the Future: Psychedelics and a Return to the Concept of Recovery in PsychiatryPublished: September 26th 2022 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Clears Investigational New Drug Application for TNX-102 SL for Treatment of Major Depressive Disorder
2
Lecanemab or Lithium? Compare Benefits, Risks, and Dose
3
Use of TMS in Treatment of Depression, Discussion With Rachel Rohaidy, MD
4
Vagus Nerve Stimulation in Treatment Resistant Depression: New Lines of Thinking
5
